fbpx
Less Radical Mesothelioma Surgery More Beneficial

January 12, 2016

Less Radical Mesothelioma Surgery More Beneficial

A mesothelioma expert with Mount Sinai in New York agrees with the finding of a recent Turkish study concerning the benefits of mesothelioma surgery. According to thoracic surgeon and researcher Raja Flores, MD, patients undergoing the less radical pleurectomy and decortication (PD) have better outcomes than those treated with extrapleural pneumonectomy (EPP).

Turkish Study of 72 Mesothelioma Patients Concludes More Radical Surgery Does Not Produce Better Survival Times

For many years, physicians have compared results of the two surgeries among mesothelioma patients. In the first type of surgery, PD, the surgeon takes out the pleura surrounding the lungs along with the diaphragm and the membrane encasing the heart. With EPP, the lung most affected by the mesothelioma tumor is also removed.
Mesothelioma doctors who prefer the less radical PD procedure believe that the risks of complications and death from EPP outweigh the benefits.
In an article published in the Journal of Thoracic and Cardiovascular Surgery, Dr. Flores noted that a recent Turkish study involving 72 mesothelioma patients supported his preference for PD over EPP. The Turkish scientists reportedly concluded that EPP patients do not survive longer than PD patients. But total lung removal does subject them to a more difficult recovery and substantial health risks.

Contact Waters Kraus Paul & Siegel to Learn More About Filing a Mesothelioma Lawsuit

If you (or a loved one) have been diagnosed with mesothelioma, contact us by email or call us at 800.226.9880 to speak with our mesothelioma lawyers, like Peter Kraus and Leslie MacLean in our Dallas office, to learn more about how we can assist you and your family with a mesothelioma lawsuit.

Our Results

$880 million award

Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.

READ THE DETAILS

$725.5 million award

A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.

READ THE DETAILS

$20 million award

Confidential settlement for the wife of a Rhode Island man who died of mesothelioma cancer after exposure to window glazing compound contaminated with asbestos.

READ THE DETAILS